| RS2135763861 |
ATM
|
Health Risk |
Conflicting classifications of pathogenicity |
Ataxia-telangiectasia syndrome, Hereditary cancer-predisposing syndrome |
| RS2135764458 |
ATM
|
Health Risk |
Likely pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2135765010 |
RASGRP2
|
Health Risk |
Likely pathogenic |
Platelet-type bleeding disorder 18, Platelet-type bleeding disorder 18 |
| RS2135767002 |
ATM
|
Health Risk |
Conflicting classifications of pathogenicity |
Ataxia-telangiectasia syndrome, Hereditary cancer-predisposing syndrome |
| RS2135773055 |
WASHC4
|
Health Risk |
Pathogenic |
Intellectual disability, autosomal recessive 43 |
| RS2135780423 |
RASGRP2
|
Health Risk |
Pathogenic |
Platelet-type bleeding disorder 18, Platelet-type bleeding disorder 18 |
| RS2135782176 |
MYRF
|
Health Risk |
Likely pathogenic |
Cardiac-urogenital syndrome, Cardiac-urogenital syndrome |
| RS2135782623 |
EHMT1
|
Health Risk |
Likely pathogenic |
— |
| RS2135783409 |
PC
|
Health Risk |
Pathogenic/Likely pathogenic |
Pyruvate carboxylase deficiency, Pyruvate carboxylase deficiency |
| RS2135784410 |
MYO7A
|
Health Risk |
Pathogenic |
— |
| RS2135784846 |
EHMT1
|
Health Risk |
Pathogenic |
Kleefstra syndrome 1, Kleefstra syndrome 1 |
| RS2135785388 |
PC
|
Health Risk |
Pathogenic |
Pyruvate carboxylase deficiency, Pyruvate carboxylase deficiency |
| RS2135785399 |
PC
|
Health Risk |
Pathogenic |
Pyruvate carboxylase deficiency, Pyruvate carboxylase deficiency |
| RS2135785787 |
EPS8
|
Health Risk |
Pathogenic |
Autosomal recessive nonsyndromic hearing loss 102, Autosomal recessive nonsyndromic hearing loss 102 |
| RS2135785861 |
MYO7A
|
Health Risk |
Pathogenic |
Autosomal recessive nonsyndromic hearing loss 2, Usher syndrome type 1 |
| RS2135785880 |
MYO7A
|
Health Risk |
Pathogenic |
Usher syndrome type 1, Usher syndrome type 1 |
| RS2135786512 |
PC
|
Health Risk |
Pathogenic |
Pyruvate carboxylase deficiency, Pyruvate carboxylase deficiency |
| RS2135786710 |
PC
|
Health Risk |
Pathogenic |
Pyruvate carboxylase deficiency, Pyruvate carboxylase deficiency |
| RS2135788673 |
PC
|
Health Risk |
Likely pathogenic |
Pyruvate carboxylase deficiency, Pyruvate carboxylase deficiency |
| RS2135789146 |
PC
|
Health Risk |
Pathogenic |
Pyruvate carboxylase deficiency, Pyruvate carboxylase deficiency |
| RS2135790424 |
PC
|
Health Risk |
Pathogenic |
Pyruvate carboxylase deficiency, Pyruvate carboxylase deficiency |
| RS2135790890 |
MYO7A
|
Health Risk |
Pathogenic |
— |
| RS2135791384 |
MYO7A
|
Health Risk |
Pathogenic |
— |
| RS2135791416 |
PC
|
Health Risk |
Likely pathogenic |
Pyruvate carboxylase deficiency, Pyruvate carboxylase deficiency |
| RS2135791473 |
MYO7A
|
Health Risk |
Pathogenic |
— |
| RS2135791768 |
MYRF
|
Health Risk |
Likely pathogenic |
Cardiac-urogenital syndrome, Cardiac-urogenital syndrome |
| RS2135795582 |
PC
|
Health Risk |
Pathogenic |
Pyruvate carboxylase deficiency, Pyruvate carboxylase deficiency |
| RS2135797740 |
ATM
|
Health Risk |
Pathogenic |
Ataxia-telangiectasia syndrome, Hereditary cancer-predisposing syndrome |
| RS2135797993 |
ATM
|
Health Risk |
Pathogenic |
Familial cancer of breast, Ataxia-telangiectasia syndrome |
| RS2135798107 |
ATM
|
Health Risk |
Pathogenic |
Ataxia-telangiectasia syndrome, Ataxia-telangiectasia syndrome |
| RS2135798153 |
ATM
|
Health Risk |
Pathogenic |
Ataxia-telangiectasia syndrome, Ataxia-telangiectasia syndrome |
| RS2135798259 |
ATM
|
Health Risk |
Conflicting classifications of pathogenicity |
Ataxia-telangiectasia syndrome, Hereditary cancer-predisposing syndrome |
| RS2135798648 |
ATM
|
Health Risk |
Pathogenic |
Ataxia-telangiectasia syndrome, Ataxia-telangiectasia syndrome |
| RS2135798718 |
MYO7A
|
Health Risk |
Pathogenic |
— |
| RS2135798786 |
MYO7A
|
Health Risk |
Pathogenic |
Usher syndrome type 1, Hearing loss |
| RS2135798857 |
PC
|
Health Risk |
Likely pathogenic |
Pyruvate carboxylase deficiency, Pyruvate carboxylase deficiency |
| RS2135799043 |
MYO7A
|
Health Risk |
Pathogenic |
— |
| RS2135799107 |
ATM
|
Health Risk |
Pathogenic |
Ataxia-telangiectasia syndrome, Ataxia-telangiectasia syndrome |
| RS2135799143 |
MYO7A
|
Health Risk |
Pathogenic |
— |
| RS2135799845 |
ATM
|
Health Risk |
Pathogenic |
Ataxia-telangiectasia syndrome, Ataxia-telangiectasia syndrome |
| RS2135800044 |
ATM
|
Health Risk |
Pathogenic/Likely pathogenic |
Ataxia-telangiectasia syndrome, Hereditary cancer-predisposing syndrome |
| RS2135800153 |
PC
|
Health Risk |
Pathogenic |
Pyruvate carboxylase deficiency, Pyruvate carboxylase deficiency |
| RS2135801094 |
ATM
|
Health Risk |
Pathogenic |
Ataxia-telangiectasia syndrome, Ataxia-telangiectasia syndrome |
| RS2135801606 |
ATM
|
Health Risk |
Pathogenic |
Abnormal central motor function, Familial cancer of breast |
| RS2135801723 |
ATM
|
Health Risk |
Pathogenic |
Ataxia-telangiectasia syndrome, Familial cancer of breast |
| RS2135802014 |
ATM
|
Health Risk |
Pathogenic |
Ataxia-telangiectasia syndrome, Ataxia-telangiectasia syndrome |
| RS2135802501 |
ATM
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2135802675 |
MYO7A
|
Health Risk |
Likely pathogenic |
Autosomal recessive nonsyndromic hearing loss 2, Autosomal recessive nonsyndromic hearing loss 2 |
| RS2135803326 |
PC
|
Health Risk |
Pathogenic |
Pyruvate carboxylase deficiency, Pyruvate carboxylase deficiency |
| RS2135804929 |
MYO7A
|
Health Risk |
Pathogenic |
Usher syndrome type 1, Usher syndrome type 1 |
| RS2135805319 |
DYNC2H1
|
Health Risk |
Likely pathogenic |
Asphyxiating thoracic dystrophy 3, Jeune thoracic dystrophy |
| RS2135805611 |
PC
|
Health Risk |
Likely pathogenic |
Pyruvate carboxylase deficiency, Pyruvate carboxylase deficiency |
| RS2135806030 |
KRAS
|
Health Risk |
Pathogenic |
Noonan syndrome 3, Noonan syndrome 3 |
| RS2135806200 |
KRAS
|
Health Risk |
Pathogenic |
— |
| RS2135806256 |
KRAS
|
Health Risk |
Pathogenic |
— |
| RS2135806346 |
KRAS
|
Health Risk |
Likely pathogenic |
RASopathy, RASopathy |
| RS2135809396 |
PC
|
Health Risk |
Pathogenic |
Pyruvate carboxylase deficiency, Pyruvate carboxylase deficiency |
| RS2135809766 |
ATM
|
Health Risk |
Pathogenic |
Ataxia-telangiectasia syndrome, Familial cancer of breast |
| RS2135809793 |
ATM
|
Health Risk |
Pathogenic |
Familial cancer of breast, Familial cancer of breast |
| RS2135810015 |
ATM
|
Health Risk |
Pathogenic |
Ataxia-telangiectasia syndrome, Ataxia-telangiectasia syndrome |
| RS2135810142 |
PCDH15
|
Health Risk |
Pathogenic |
— |
| RS2135810212 |
ATM
|
Health Risk |
Pathogenic |
Ataxia-telangiectasia syndrome, Hereditary cancer-predisposing syndrome |
| RS2135810742 |
PCDH15
|
Health Risk |
Pathogenic |
— |
| RS2135811484 |
ATM
|
Health Risk |
Pathogenic |
Familial ovarian cancer, Familial ovarian cancer |
| RS2135812938 |
ATM
|
Health Risk |
Conflicting classifications of pathogenicity |
Ataxia-telangiectasia syndrome, Hereditary cancer-predisposing syndrome |
| RS2135813862 |
PC
|
Health Risk |
Pathogenic |
Pyruvate carboxylase deficiency, Pyruvate carboxylase deficiency |
| RS2135814096 |
ATM
|
Health Risk |
Pathogenic |
Ataxia-telangiectasia syndrome, Ataxia-telangiectasia syndrome |
| RS2135814786 |
PC
|
Health Risk |
Pathogenic |
Pyruvate carboxylase deficiency, Pyruvate carboxylase deficiency |
| RS2135818776 |
HNF1A
|
Health Risk |
Pathogenic |
Maturity-onset diabetes of the young type 3, Monogenic diabetes |
| RS2135819325 |
HNF1A
|
Health Risk |
Pathogenic |
Monogenic diabetes, Maturity-onset diabetes of the young |
| RS2135819349 |
HNF1A
|
Health Risk |
Likely pathogenic |
Monogenic diabetes, Monogenic diabetes |
| RS2135819354 |
HNF1A
|
Health Risk |
Pathogenic |
Monogenic diabetes, Monogenic diabetes |
| RS2135819368 |
HNF1A
|
Health Risk |
Likely pathogenic |
Monogenic diabetes, Monogenic diabetes |
| RS2135819387 |
HNF1A
|
Health Risk |
Pathogenic |
Monogenic diabetes, Monogenic diabetes |
| RS2135819400 |
HNF1A
|
Health Risk |
Likely pathogenic |
Monogenic diabetes, Monogenic diabetes |
| RS2135819422 |
HNF1A
|
Health Risk |
Likely pathogenic |
Monogenic diabetes, Monogenic diabetes |
| RS2135819438 |
HNF1A
|
Health Risk |
Pathogenic |
Monogenic diabetes, Monogenic diabetes |
| RS2135819527 |
HNF1A
|
Health Risk |
Pathogenic |
Monogenic diabetes, Monogenic diabetes |
| RS2135819552 |
HNF1A
|
Health Risk |
Likely pathogenic |
Monogenic diabetes, Monogenic diabetes |
| RS2135819583 |
HNF1A
|
Health Risk |
Likely pathogenic |
Monogenic diabetes, Monogenic diabetes |
| RS2135819653 |
HNF1A
|
Health Risk |
Pathogenic |
— |
| RS2135819670 |
HNF1A
|
Health Risk |
Pathogenic |
Monogenic diabetes, Monogenic diabetes |
| RS2135819704 |
HNF1A
|
Health Risk |
Pathogenic |
Monogenic diabetes, Monogenic diabetes |
| RS2135819737 |
HNF1A
|
Health Risk |
Likely pathogenic |
Maturity-onset diabetes of the young, Maturity-onset diabetes of the young |
| RS2135819834 |
HNF1A
|
Health Risk |
Pathogenic |
Monogenic diabetes, Monogenic diabetes |
| RS2135819895 |
HNF1A
|
Health Risk |
Pathogenic |
Monogenic diabetes, Monogenic diabetes |
| RS2135819908 |
HNF1A
|
Health Risk |
Likely pathogenic |
Monogenic diabetes, Monogenic diabetes |
| RS2135819929 |
HNF1A
|
Health Risk |
Pathogenic |
Monogenic diabetes, Monogenic diabetes |
| RS2135819979 |
HNF1A
|
Health Risk |
Likely pathogenic |
Monogenic diabetes, Monogenic diabetes |
| RS2135820197 |
HNF1A
|
Health Risk |
Likely pathogenic |
Monogenic diabetes, Monogenic diabetes |
| RS2135820267 |
HNF1A
|
Health Risk |
Likely pathogenic |
Monogenic diabetes, Monogenic diabetes |
| RS2135820404 |
HNF1A
|
Health Risk |
Pathogenic |
Monogenic diabetes, Monogenic diabetes |
| RS2135820413 |
HNF1A
|
Health Risk |
Likely pathogenic |
Monogenic diabetes, Maturity-onset diabetes of the young |
| RS2135820424 |
HNF1A
|
Health Risk |
Pathogenic |
Monogenic diabetes, Monogenic diabetes |
| RS2135822119 |
PC
|
Health Risk |
Likely pathogenic |
Pyruvate carboxylase deficiency, Pyruvate carboxylase deficiency |
| RS2135822173 |
PC
|
Health Risk |
Likely pathogenic |
Pyruvate carboxylase deficiency, Pyruvate carboxylase deficiency |
| RS2135822512 |
PYGM
|
Health Risk |
Pathogenic |
Glycogen storage disease, type V |
| RS2135822551 |
SHANK2
|
Health Risk |
Likely pathogenic |
Autism, susceptibility to |
| RS2135822918 |
SHANK2
|
Health Risk |
Pathogenic |
— |
| RS2135823216 |
PYGM
|
Health Risk |
Pathogenic/Likely pathogenic |
Glycogen storage disease, type V |